vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.

MODIV INDUSTRIAL, INC. is the larger business by last-quarter revenue ($11.1M vs $8.1M, roughly 1.4× Arcellx, Inc.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -766.0%, a 777.0% gap on every dollar of revenue. On growth, MODIV INDUSTRIAL, INC. posted the faster year-over-year revenue change (-5.6% vs -79.3%). Over the past eight quarters, MODIV INDUSTRIAL, INC.'s revenue compounded faster (-3.8% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.

ACLX vs MDV — Head-to-Head

Bigger by revenue
MDV
MDV
1.4× larger
MDV
$11.1M
$8.1M
ACLX
Growing faster (revenue YoY)
MDV
MDV
+73.7% gap
MDV
-5.6%
-79.3%
ACLX
Higher net margin
MDV
MDV
777.0% more per $
MDV
11.0%
-766.0%
ACLX
Faster 2-yr revenue CAGR
MDV
MDV
Annualised
MDV
-3.8%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
MDV
MDV
Revenue
$8.1M
$11.1M
Net Profit
$-62.3M
$1.2M
Gross Margin
Operating Margin
-847.6%
45.8%
Net Margin
-766.0%
11.0%
Revenue YoY
-79.3%
-5.6%
Net Profit YoY
-765.1%
-22.0%
EPS (diluted)
$-1.13
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
MDV
MDV
Q4 25
$11.1M
Q3 25
$11.7M
Q2 25
$11.8M
Q1 25
$8.1M
$11.8M
Q4 24
$15.3M
$11.7M
Q3 24
$26.0M
$11.7M
Q2 24
$27.4M
$11.4M
Q1 24
$39.3M
$12.0M
Net Profit
ACLX
ACLX
MDV
MDV
Q4 25
$1.2M
Q3 25
$1.0M
Q2 25
$-2.0M
Q1 25
$-62.3M
$829.0K
Q4 24
$-47.1M
$1.6M
Q3 24
$-25.9M
$-587.0K
Q2 24
$-27.2M
$1.3M
Q1 24
$-7.2M
$3.7M
Operating Margin
ACLX
ACLX
MDV
MDV
Q4 25
45.8%
Q3 25
41.4%
Q2 25
9.8%
Q1 25
-847.6%
40.2%
Q4 24
-348.2%
45.4%
Q3 24
-129.1%
42.0%
Q2 24
-127.8%
44.6%
Q1 24
-40.3%
55.6%
Net Margin
ACLX
ACLX
MDV
MDV
Q4 25
11.0%
Q3 25
9.0%
Q2 25
-17.1%
Q1 25
-766.0%
7.0%
Q4 24
-308.4%
13.3%
Q3 24
-99.4%
-5.0%
Q2 24
-99.3%
11.6%
Q1 24
-18.3%
31.1%
EPS (diluted)
ACLX
ACLX
MDV
MDV
Q4 25
$0.02
Q3 25
$0.00
Q2 25
$-0.32
Q1 25
$-1.13
$-0.01
Q4 24
$-0.87
$0.07
Q3 24
$-0.48
$-0.18
Q2 24
$-0.51
$0.03
Q1 24
$-0.14
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
MDV
MDV
Cash + ST InvestmentsLiquidity on hand
$543.3M
$14.4M
Total DebtLower is stronger
$261.5M
Stockholders' EquityBook value
$416.9M
$162.7M
Total Assets
$648.1M
$476.5M
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
MDV
MDV
Q4 25
$14.4M
Q3 25
$8.3M
Q2 25
$5.8M
Q1 25
$543.3M
$6.2M
Q4 24
$587.4M
$11.5M
Q3 24
$574.3M
$6.8M
Q2 24
$516.7M
$18.9M
Q1 24
$573.9M
$18.4M
Total Debt
ACLX
ACLX
MDV
MDV
Q4 25
$261.5M
Q3 25
$279.7M
Q2 25
$279.7M
Q1 25
$279.7M
Q4 24
$279.8M
Q3 24
$279.7M
Q2 24
$279.7M
Q1 24
$279.6M
Stockholders' Equity
ACLX
ACLX
MDV
MDV
Q4 25
$162.7M
Q3 25
$164.8M
Q2 25
$165.6M
Q1 25
$416.9M
$171.1M
Q4 24
$454.8M
$190.1M
Q3 24
$483.0M
$186.3M
Q2 24
$487.2M
$187.0M
Q1 24
$496.6M
$188.0M
Total Assets
ACLX
ACLX
MDV
MDV
Q4 25
$476.5M
Q3 25
$499.6M
Q2 25
$498.9M
Q1 25
$648.1M
$506.8M
Q4 24
$711.3M
$507.8M
Q3 24
$764.9M
$507.4M
Q2 24
$734.3M
$519.5M
Q1 24
$779.7M
$522.5M
Debt / Equity
ACLX
ACLX
MDV
MDV
Q4 25
1.61×
Q3 25
1.70×
Q2 25
1.69×
Q1 25
1.63×
Q4 24
1.47×
Q3 24
1.50×
Q2 24
1.50×
Q1 24
1.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
MDV
MDV
Operating Cash FlowLast quarter
$-63.1M
$15.0M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
12.34×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
MDV
MDV
Q4 25
$15.0M
Q3 25
$4.1M
Q2 25
$3.9M
Q1 25
$-63.1M
$3.0M
Q4 24
$-46.0M
$18.2M
Q3 24
$30.7M
$5.1M
Q2 24
$-36.2M
$4.7M
Q1 24
$-31.9M
$3.0M
Free Cash Flow
ACLX
ACLX
MDV
MDV
Q4 25
Q3 25
Q2 25
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
FCF Margin
ACLX
ACLX
MDV
MDV
Q4 25
Q3 25
Q2 25
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Capex Intensity
ACLX
ACLX
MDV
MDV
Q4 25
Q3 25
Q2 25
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
Cash Conversion
ACLX
ACLX
MDV
MDV
Q4 25
12.34×
Q3 25
3.95×
Q2 25
Q1 25
3.68×
Q4 24
11.72×
Q3 24
Q2 24
3.55×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons